A recent study suggested that elevated RUNX2 expression, along with the suppression of RUNX2/pAKT signalling, may reactivate p53 function and increase the sensitivity of osteosarcoma cells to apoptosis [54,55]. Here, TP53 is linked to osteosarcoma.